CCP-340B Practice Test

Certifications > CCP-340B > Practice Test

CCP-340B Practice Test (V1)

Dive into practice questions

Question 1

A patient is seen at a 340B-eligible hospital's outpatient oncology clinic. The oncologist writes a prescription, which the patient fills at the hospital's on-site pharmacy. To be considered a 340B-eligible patient for this dispense, which condition must be met?

  1. The patient must have an income below 200% of the Federal Poverty Level.
  2. The covered entity must maintain records of the patient's healthcare and the provider must have prescriptive authority.
  3. The patient must be uninsured or have Medicaid as their primary insurance.
  4. The prescription must be for a medication that is included on the hospital's formulary.

Question 2

A covered entity's compliance pharmacist discovers that a 340B-purchased drug was inadvertently dispensed to a patient who was admitted as an inpatient. This constitutes a diversion. What is the entity's immediate responsibility upon discovering this non-compliance?

  1. Report the individual pharmacist who dispensed the drug to the state board of pharmacy.
  2. Wait until the next HRSA audit to disclose the finding to the auditor.
  3. Contact the manufacturer, explain the error, and arrange for repayment of the 340B discount for that specific dispense.
  4. Immediately remove the drug from the 340B program formulary to prevent future errors.

Question 3

The GPO (Group Purchasing Organization) prohibition for a DSH-covered entity applies to which of the following scenarios?

  1. Using a GPO to purchase any medication for an inpatient admitted to the hospital.
  2. Using a GPO to purchase any covered outpatient drug for a 340B-eligible patient.
  3. Using a GPO to purchase medical supplies, such as syringes and gloves.
  4. Using a GPO to purchase vaccines for a community immunization clinic.

Question 4

During a self-audit, a 340B compliance pharmacist reviews records for a contract pharmacy. Which finding would represent a violation of the duplicate discount prohibition?

  1. A 340B-purchased drug was dispensed to an eligible patient, and the claim was submitted to their commercial insurance plan.
  2. A 340B-purchased drug was dispensed to an eligible patient who also has Medicaid, and the claim was submitted to Medicaid for reimbursement including a claim for a federal rebate.
  3. A non-340B drug (WAC-purchased) was dispensed to a Medicaid patient from the contract pharmacy's inventory.
  4. A 340B-purchased drug was dispensed to an eligible patient who paid for the medication with cash.

Answer Key

  • Question 1: B. The covered entity must maintain records of the patient's healthcare and the provider must have prescriptive authority. (This is the core HRSA definition of a 340B patient; it is not based on income or insurance status.)
  • Question 2: C. Contact the manufacturer, explain the error, and arrange for repayment of the 340B discount for that specific dispense. (This is the required corrective action for a diversion identified through self-disclosure.)
  • Question 3: B. Using a GPO to purchase any covered outpatient drug for a 340B-eligible patient. (The GPO prohibition is specific to covered outpatient drugs for DSH and children's hospitals.)
  • Question 4: B. A 340B-purchased drug was dispensed to an eligible patient who also has Medicaid, and the claim was submitted to Medicaid for reimbursement including a claim for a federal rebate. (This is the definition of a duplicate discount: the manufacturer gives a 340B price upfront and then also pays a Medicaid rebate on the same drug.)